Vitalbeat Enabling Big Data Cloud for Predictive Analysis
and Informatics for Readmission Modeling
Provides Remote Patient Data and Care Management Modeling for At-risk
Heart Failure Patients with Vitalbeat, a Specially Designed Patient
Adherence and Monitoring System Using Standard Mobile Medical Technology
USC Body Computing Conference,
Los Angeles – Oct 5, 2012 –
Aventyn Inc.,
an innovative provider of core to cloud secure connected clinical
information systems for remote patient monitoring and chronic disease
management solutions made this announcement at the sixth annual
USC BCC 6.0
event being held at USC.
Heart failure is a common cardiovascular problem which is increasing in
both prevalence and incidence globally and is associated with
substantial morbidity and mortality. Management of heart failure
patients is complex and has become a priority world over. Effective
methods to keep heart failure patients out of the hospital are
essential, both in the interests of the patient’s health, as well as to
reduce the burden on the health care system. A rational and sustainable
approach requires care coordination in identifying at-risk patients, a
personalized strategy for vitals monitoring, diet and medication
adherence combined with the right education.
Vitalbeat-PAIR enables platform tools for combining structured health
record data, imaging modalities and unstructured patient entered vitals,
bio-sensor device data from diverse points of source to analyze and
reduce risk of patient readmission and ER visits. The Vitalbeat system
was developed for Phase 1 of the Remote-HF-1 international, multi-center
clinical study.
“Big data and data analytics are going to be a big part of improving
patient outcomes and reducing health care costs,” said Dr. Leslie A.
Saxon, the Executive Director of the University of Southern California
Center for Body Computing, a digital health innovation center.
“Working smarter to preserve medical care expenditure for true
investment in innovative therapies can be enabled by data solutions for
expensive problems like heart failure re-admission.”
“The USC Body Computing Conference is a unique event that has been
bringing together domain experts, researchers and business leaders for
the advancement of innovative care delivery models utilizing
bio-sensors, wireless technology and gamification for the sixth year. We
are honored to be invited by Dr. Leslie Saxon to participate at this
event.” said Navin Govind, founder and CEO at Aventyn. “Providing
innovative tools for clinicians and medical researchers to identify and
isolate root causes for readmissions of at-risk patients is a key spoke
in the quality of life wheel. Most importantly, in addition to risk
prediction, we can now iteratively focus on clinical event prediction
towards improving patient outcomes and safety.”
Together with its strategic industry partners, Aventyn collaborates with
academia, clinical research and provider care coordinators to leverage
innovative health technologies through the Aventyn Health Innovation
Ecosystem launched in February 2012. The ecosystem is dedicated to using
clinical evidence- based solutions developed by Aventyn sponsored
clinical studies to provide scalable, low cost mobile patient monitoring
plans for improved chronic health care and solutions to fight long term
disease. Contact us at
vitalbeat@aventyn.com
to arrange demonstrations,
participation in Phase 2 of the Remote-HF-2 trial, future mhealth
clinical studies and first round investment.
About Vitalbeat™
Vitalbeat is a mobile remote patient monitoring and integrated chronic
disease management system. Vitalbeat was developed for Phase 1 of the
Remote-HF international, multi-center clinical study conducted at:
Vivus-BMJ Heart Centre and Narayana Hrudayalaya in Bangalore, India,
Karolinska University Hospital at Solna in Sweden, Saint Francis
Hospital, Roslyn, New York and Winthrop-University Hospital, Mineola,
New York in the USA.
Mobile devices enabled patients and clinicians in the study to stay
connected and informed using the Vitalbeat remote patient monitoring and
chronic disease management system. This personalized patient software
solution was tested for remotely monitoring heart failure patients and
securely sharing patient vital sign information with clinicians to care
for patients recruited in the study. The trial is registered in the
United States FDA clinical trials registration site under NCT01430936.
The two phase trial is sponsored by Aventyn in collaboration with BMS
Hospital Trust in India, AT&T Healthcare, University of California and
Zephyr Technology in the USA. Phase 2 of the trial is a structured
two-year study conducted in collaboration with pharma and life science
companies, wearable sensor-based medical device companies and global
cloud, mobile service providers.
About USC BCC
The University of Southern California Center for Body Computing is an
interdisciplinary brain trust that brings together USC's Keck School of
Medicine and world-renowned School of Cinematic Arts with the
university's schools of Business and Engineering.
The CBC has a track record of creating health solutions from early stage
scientific advances and discoveries into commercially viable products,
in preventives, diagnostics, devices, and tools that improve patient
care and advance public health.
The USC CBC’s purpose is to creatively synthesize medicine, engineering,
business, communications, and entertainment arts into new paradigms that
will innovatively enhance the quality of life, especially for the 2
billion people worldwide who lack access to healthcare.
More information:
www.uscbodycomputing.org
About Aventyn Inc.
Aventyn Inc. is an early stage health technology company seamlessly
connecting clinicians and patients with our secure core to cloud
clinical information processing platform for improved quality of life.
Our CLIP®Care EMR solutions with CareLock™ health information security
and integrated wireless bio-sensor capability enable continuity of care
anytime, anywhere and anyplace. Vitalbeat–Integrated Chronic Disease
Management™ patient personalized solutions are tailored for home and
remote monitoring. Healthcare providers, insurance payers and
pharma-lifescience companies use our patient personalized platform along
with our medical device partners to document baseline patient chronic
conditions, mobile patient monitoring, and population care management
with preventive and wellness education. We offer bundled and per patient
per month subscription solutions with strategic provider and payer
partners. Aventyn UK Ltd, Aventyn Sweden (filial) and Aventyn India are
wholly owned subsidiaries of Aventyn Inc., USA.
CONTACT:
Puja Chandler
Email: puja@aventyn.com
Phone: +1.858.232.2698
INVESTOR RELATIONS:
Magnus Gunnarsson
Email: investor@aventyn.com
Phone: +1.858.344.6172
*Other names, trademarks and brands are properties of their respective
owners.
